Kissei Pharmaceutical Co., Ltd. (4547.T) - Quarterly Income Statement

Home
4547.T
Financials

3495 (JPY) • At close September 19, 2024

Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1	2019 Q4	2019 Q3	2019 Q2	2019 Q1	2018 Q4	2018 Q3	2018 Q2	2018 Q1	2017 Q4	2017 Q3	2017 Q2	2017 Q1	2016 Q4	2016 Q3	2016 Q2	2016 Q1	2015 Q4	2015 Q3	2015 Q2	2015 Q1	2014 Q4	2014 Q3	2014 Q2	2014 Q1	2013 Q4	2013 Q3	2013 Q2	2013 Q1	2012 Q4	2012 Q3	2012 Q2	2012 Q1	2011 Q4	2011 Q3	2011 Q2	2011 Q1	2010 Q4	2010 Q3	2010 Q2	2010 Q1	2009 Q4	2009 Q3	2009 Q2	2009 Q1	2008 Q4	2008 Q3	2008 Q2
Revenue Numbers are in millions	21,164	17,720	20,881	17,665	19,313	15,858	18,771	16,579	16,285	15,296	17,697	15,753	16,635	16,851	19,910	16,221	16,062	14,682	17,003	15,450	16,110	17,043	19,587	17,815	17,857	17,217	20,194	17,740	18,847	17,098	18,772	16,678	19,159	17,546	20,152	16,918	16,681	17,493	18,011	18,769	15,835	17,048	21,430	15,617	16,305	15,983	17,187	14,945	14,379	16,052	16,767	16,329	15,521	16,975	16,451	15,111	15,849	14,629	15,839	15,893	15,775	18,286	15,958	15,105
Cost of Revenue Numbers are in millions	10,283	8,944	10,617	8,947	9,730	8,869	9,569	8,545	8,135	8,167	9,052	8,155	8,769	9,646	10,489	8,383	7,803	7,576	7,902	6,797	6,065	6,564	6,658	7,115	6,398	6,533	7,018	6,077	6,250	6,387	6,097	5,764	6,828	6,595	6,216	5,652	5,119	6,362	6,061	6,486	5,154	6,637	6,210	5,018	5,317	6,217	5,747	4,703	4,479	6,125	5,558	5,773	5,443	7,333	5,479	4,910	4,769	5,434	5,172	5,526	5,585	7,737	5,302	5,616
Gross Profit Numbers are in millions	10,881	8,776	10,264	8,718	9,583	6,989	9,202	8,034	8,150	7,129	8,645	7,598	7,866	7,205	9,421	7,838	8,259	7,106	9,101	8,653	10,045	10,479	12,929	10,700	11,459	10,684	13,176	11,663	12,597	10,711	12,675	10,914	12,331	10,951	13,936	11,266	11,562	11,131	11,950	12,283	10,681	10,411	15,220	10,599	10,988	9,766	11,440	10,242	9,900	9,927	11,209	10,556	10,078	9,642	10,972	10,201	11,080	9,195	10,667	10,367	10,190	10,549	10,656	9,489
Gross Profit Ratio Numbers are in millions	0.514	0.495	0.492	0.494	0.496	0.441	0.49	0.485	0.5	0.466	0.489	0.482	0.473	0.428	0.473	0.483	0.514	0.484	0.535	0.56	0.624	0.615	0.66	0.601	0.642	0.621	0.652	0.657	0.668	0.626	0.675	0.654	0.644	0.624	0.692	0.666	0.693	0.636	0.663	0.654	0.675	0.611	0.71	0.679	0.674	0.611	0.666	0.685	0.689	0.618	0.669	0.646	0.649	0.568	0.667	0.675	0.699	0.629	0.673	0.652	0.646	0.577	0.668	0.628
Reseach & Development Expenses Numbers are in millions	0	2,712	2,263	2,298	2,201	2,748	2,443	2,775	2,425	10,363	3,638	1,979	2,189	9,626	0	0	0	10,767	0	0	0	15,711	0	0	0	14,179	0	0	0	13,877	0	0	0	14,106	0	0	0	14,488	0	0	0	11,298	0	0	0	10,312	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
General & Administrative Expenses Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Selling & Marketing Expenses Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
SG&A Numbers are in millions	8,723	6,212	5,853	6,037	7,949	5,863	5,639	6,016	8,019	4,479	9,209	7,620	5,384	2,720	8,276	7,426	6,625	3,927	8,696	8,380	7,984	7,541	12,213	9,432	8,473	5,901	8,840	9,358	10,783	4,803	9,411	9,760	9,011	2,989	7,733	8,701	9,083	3,729	8,488	9,564	8,094	2,362	8,401	8,925	7,817	2,133	7,937	8,701	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Expenses Numbers are in millions	0	17	2	-1	17	-163	25	101	95	2	183	45	51	35	9	78	9	96	33	25	17	47	11	22	13	38	11	17	15	14	30	14	19	22	-24	30	40	16	-149	226	26	-94	81	86	17	-60	-187	143	295	67	236	43	351	57	228	13	373	64	224	24	281	244	191	-17
Operating Expenses Numbers are in millions	8,723	8,924	8,116	8,335	7,949	8,611	8,082	8,791	8,019	8,238	9,209	7,620	7,573	8,890	8,276	7,426	6,625	7,988	8,696	8,380	7,984	9,245	12,213	9,432	8,473	9,251	8,840	9,358	10,783	9,958	9,411	9,760	9,011	11,922	7,733	8,701	9,083	11,564	8,488	9,564	8,094	9,774	8,401	8,925	7,817	9,138	7,937	8,701	7,810	8,917	8,319	8,716	8,353	8,705	8,229	9,484	9,014	9,041	8,106	8,183	8,503	8,871	8,629	8,906
Operating Income Numbers are in millions	2,158	-148	2,149	382	1,633	-1,621	1,117	-755	130	-1,108	-564	-23	293	-1,685	1,146	411	1,633	-882	405	273	2,061	1,232	718	1,268	2,984	1,434	4,335	2,305	1,813	753	3,265	1,153	3,320	-971	6,201	2,566	2,478	-432	3,461	2,718	2,587	639	6,819	1,673	3,170	628	3,503	1,541	2,089	1,010	2,891	1,841	1,723	939	2,742	715	2,066	154	2,559	2,184	1,686	1,680	2,023	581
Operating Income Ratio Numbers are in millions	0.102	-0.008	0.103	0.022	0.085	-0.102	0.06	-0.046	0.008	-0.072	-0.032	-0.001	0.018	-0.1	0.058	0.025	0.102	-0.06	0.024	0.018	0.128	0.072	0.037	0.071	0.167	0.083	0.215	0.13	0.096	0.044	0.174	0.069	0.173	-0.055	0.308	0.152	0.149	-0.025	0.192	0.145	0.163	0.037	0.318	0.107	0.194	0.039	0.204	0.103	0.145	0.063	0.172	0.113	0.111	0.055	0.167	0.047	0.13	0.011	0.162	0.137	0.107	0.092	0.127	0.038
Total Other Income Expenses Net Numbers are in millions	3,363	3,497	1,449	2,771	2,713	6,311	3,455	3,032	2,009	8,902	2,004	3,023	3,980	591	1,714	3,129	537	719	1,518	167	369	301	226	-177	568	-270	727	399	953	-102	1,054	156	517	-93	534	-151	571	206	793	512	620	-149	498	272	478	193	425	-507	119	283	53	37	236	121	157	-362	-48	35	258	-347	83	-2,562	-414	-430
Income Before Tax Numbers are in millions	5,521	3,349	3,598	3,153	4,349	4,690	4,572	2,277	2,141	7,794	1,440	3,000	4,273	-1,094	2,859	3,540	2,171	-163	1,923	439	2,431	1,534	944	1,090	3,553	1,164	5,063	2,703	2,767	650	4,319	1,310	3,837	-1,064	6,736	2,415	3,049	-226	4,255	3,230	3,207	489	7,317	1,945	3,649	822	3,927	1,034	2,209	1,293	2,943	1,877	1,961	1,058	2,900	355	2,018	189	2,819	1,837	1,770	-884	1,613	153
Income Before Tax Ratio Numbers are in millions	0.261	0.189	0.172	0.178	0.225	0.296	0.244	0.137	0.131	0.51	0.081	0.19	0.257	-0.065	0.144	0.218	0.135	-0.011	0.113	0.028	0.151	0.09	0.048	0.061	0.199	0.068	0.251	0.152	0.147	0.038	0.23	0.079	0.2	-0.061	0.334	0.143	0.183	-0.013	0.236	0.172	0.203	0.029	0.341	0.125	0.224	0.051	0.228	0.069	0.154	0.081	0.176	0.115	0.126	0.062	0.176	0.023	0.127	0.013	0.178	0.116	0.112	-0.048	0.101	0.01
Income Tax Expense Numbers are in millions	1,416	511	903	720	1,025	800	1,197	564	485	1,665	252	958	600	18	770	843	467	542	509	277	413	294	-2	481	813	145	1,283	509	661	-49	1,160	237	1,003	-440	1,875	721	784	44	1,307	991	935	93	2,384	583	1,223	173	1,349	649	779	469	1,460	732	627	300	1,098	147	777	5	1,019	668	537	-459	677	74
Net Income Numbers are in millions	4,106	2,823	2,659	2,413	3,265	3,861	3,341	1,691	1,635	6,102	1,153	2,022	3,644	-1,155	2,044	2,671	1,725	-725	1,392	138	2,012	1,211	933	596	2,741	993	3,772	2,179	2,101	683	3,153	1,056	2,834	-642	4,860	1,682	2,265	-286	2,947	2,235	2,269	378	4,935	1,353	2,427	650	2,552	374	1,443	813	1,485	1,134	1,337	750	1,805	202	1,246	166	1,798	1,171	1,235	-432	936	75
Net Income Ratio Numbers are in millions	0.194	0.159	0.127	0.137	0.169	0.243	0.178	0.102	0.1	0.399	0.065	0.128	0.219	-0.069	0.103	0.165	0.107	-0.049	0.082	0.009	0.125	0.071	0.048	0.033	0.153	0.058	0.187	0.123	0.111	0.04	0.168	0.063	0.148	-0.037	0.241	0.099	0.136	-0.016	0.164	0.119	0.143	0.022	0.23	0.087	0.149	0.041	0.148	0.025	0.1	0.051	0.089	0.069	0.086	0.044	0.11	0.013	0.079	0.011	0.114	0.074	0.078	-0.024	0.059	0.005
EPS Numbers are in millions	92.88	63.8	59.17	52.67	70.95	83.72	72.45	36.67	35.45	132.32	25	43.85	79.02	-24.83	43.75	57.18	36.94	-15.52	29.8	2.95	43.08	25.92	19.97	12.76	58.67	21.26	80.74	45.1	43.5	14.14	65.26	21.58	57.94	-13.12	99.33	34.38	46.31	-5.85	60.23	43.42	44.1	7.34	95.88	26.29	47.15	12.63	49.58	7.27	28.04	15.79	28.85	21.09	24.87	13.82	33.26	3.72	22.97	3.06	33.12	21.57	22.75	-7.96	17.25	1.38
EPS Diluted Numbers are in millions	92.88	63.8	59.17	52.67	70.95	83.72	72.45	36.67	35.45	132.32	25	43.85	79.02	-24.72	43.75	57.18	36.94	-15.52	29.8	2.95	43.08	25.92	19.97	12.76	58.67	21.26	80.74	45.1	43.5	14.14	65.26	21.58	57.94	-13.12	99.33	34.38	46.31	-5.85	60.23	43.42	44.1	7.34	95.88	26.29	47.15	12.63	49.58	7.27	28.04	15.79	28.85	21.09	24.87	13.82	33.26	3.72	22.97	3.06	33.12	21.57	22.75	-7.96	17.25	1.38
EBITDA Numbers are in millions	3,279	990	2,655	459	2,270	-1,454	1,660	-503	816	-897	116	256	929	-1,568	1,578	661	2,114	-599	863	411	2,580	1,396	1,098	1,349	3,525	1,667	4,752	2,386	2,245	855	3,693	1,247	3,639	-912	6,534	2,711	2,957	-308	4,121	3,088	2,929	570	7,202	1,879	3,544	645	3,908	1,702	2,393	1,772	3,836	2,538	2,682	1,732	3,704	1,398	3,165	1,002	3,625	3,036	2,752	2,946	3,214	625
EBITDA Ratio Numbers are in millions	0.155	0.056	0.127	0.026	0.118	-0.092	0.088	-0.03	0.05	-0.059	0.007	0.016	0.056	-0.093	0.079	0.041	0.132	-0.041	0.051	0.027	0.16	0.082	0.056	0.076	0.197	0.097	0.235	0.134	0.119	0.05	0.197	0.075	0.19	-0.052	0.324	0.16	0.177	-0.018	0.229	0.165	0.185	0.033	0.336	0.12	0.217	0.04	0.227	0.114	0.166	0.11	0.229	0.155	0.173	0.102	0.225	0.093	0.2	0.068	0.229	0.191	0.174	0.161	0.201	0.041

Kissei Pharmaceutical Co., Ltd.

TSE:4547.T Add to watchlist

TSE:4547.T